Darya-Varia Laboratoria Tbk PT
Mr. Clinton A. Campos Hess graduated from the Wharton School of the University of Pennsylvania (Pennsylvania, USA) with a Bachelor of Science degree in Economics, with Dual Majors in Multinational Management and Finance. He was first appointed as President Commissioner at the AGMS held on June 2019. He has served as a Commissioner of the Company since June 2006 and was a Director of the Company in 2005. Mr. Campos Hess joined the management team of the Unilab and Unam Group of Companies in 1993. Currently, he serves as Vice Chairman, President and CEO of both Unilab and Unam, Chairman of the Board of Univet Nutrition and Animal Healthcare Company (UNAHCO), President Director of PT Etana Biotechnologies Indonesia, Vice President Commissioner of PT Medifarma Laboratories, as well as President Commissioner of PT Medifarma Life Sciences.
This person is not in any offices
Darya-Varia Laboratoria Tbk PT
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. The Company's major business activities are classified into three business segments: Prescription drugs, Consumer health products and Export and toll manufacturing services. Darya-Varia's leading products under the Prescription drugs segment are namely Mediamer B6 and Obimin - AF, drugs under woman health segment; Thrombo Aspilets, a cardiac medication, and Trifluoperazine, a central nervous system agent. Its products under the Consumer health products segment include Enervon-C, a health supplement and Decolgen FX Tablet, a flu treatment medicine. Other products of the Company include medicated plasters, lotions and creams.